198 related articles for article (PubMed ID: 33152065)
1. The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up.
Bjerring AW; Fosså SD; Haugnes HS; Nome R; Stokke TM; Haugaa KH; Kiserud CE; Edvardsen T; Sarvari SI
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):443-450. PubMed ID: 33152065
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk in long-term survivors of testicular cancer.
Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome.
Bucher-Johannessen C; Page CM; Haugen TB; Wojewodzic MW; Fosså SD; Grotmol T; Haugnes HS; Rounge TB
Clin Epigenetics; 2019 Dec; 11(1):179. PubMed ID: 31796056
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure and body mass index in long-term survivors of testicular cancer.
Sagstuen H; Aass N; Fosså SD; Dahl O; Klepp O; Wist EA; Wilsgaard T; Bremnes RM
J Clin Oncol; 2005 Aug; 23(22):4980-90. PubMed ID: 16051950
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular and cardiac autonomic function in survivors of testicular cancer.
Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Hoekstra HJ; Sluiter WJ; Gietema JA
Eur J Clin Invest; 2005 Feb; 35(2):99-103. PubMed ID: 15667580
[TBL] [Abstract][Full Text] [Related]
7. The impact of cisplatinum-based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer.
Murbraech K; Solheim O; Aulie HM; Fossa SD; Aakhus S
ESC Heart Fail; 2015 Sep; 2(3):142-149. PubMed ID: 28834675
[TBL] [Abstract][Full Text] [Related]
8. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
[TBL] [Abstract][Full Text] [Related]
9. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.
Haugnes HS; Stenklev NC; Brydøy M; Dahl O; Wilsgaard T; Laukli E; Fosså SD
Acta Oncol; 2018 Aug; 57(8):1075-1083. PubMed ID: 29384420
[TBL] [Abstract][Full Text] [Related]
10. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.
Ho E; Brown A; Barrett P; Morgan RB; King G; Kennedy MJ; Murphy RT
Heart; 2010 May; 96(9):701-7. PubMed ID: 20424152
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.
Altena R; de Haas EC; Nuver J; Brouwer CA; van den Berg MP; Smit AJ; Postma A; Sleijfer DT; Gietema JA
Br J Cancer; 2009 Jun; 100(12):1861-6. PubMed ID: 19455138
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer.
Altena R; Hummel YM; Nuver J; Smit AJ; Lefrandt JD; de Boer RA; Voors AA; van den Berg MP; de Vries EG; Boezen HM; Gietema JA
Ann Oncol; 2011 Oct; 22(10):2286-93. PubMed ID: 21878427
[TBL] [Abstract][Full Text] [Related]
13. Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.
Hellesnes R; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Kvammen Ø; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
J Clin Oncol; 2021 Feb; 39(4):308-318. PubMed ID: 33356420
[TBL] [Abstract][Full Text] [Related]
14. Change in telomere length and cardiovascular risk factors in testicular cancer survivors.
Volders ELD; Meijer C; Steeneken LS; Lubberts S; Zwart N; van Roon AM; Lefrandt JD; de Jong IJ; Demaria M; Nuver J; Gietema JA
Urol Oncol; 2024 Jan; 42(1):24.e1-24.e8. PubMed ID: 38052712
[TBL] [Abstract][Full Text] [Related]
15. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for testicular cancer induces acute alterations in diastolic heart function.
van Schinkel LD; Willemse PM; van der Meer RW; Burggraaf J; van Elderen SG; Smit JW; de Roos A; Osanto S; Lamb HJ
Br J Cancer; 2013 Aug; 109(4):891-6. PubMed ID: 23922115
[TBL] [Abstract][Full Text] [Related]
17. The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up.
Skalleberg J; Småstuen MC; Oldenburg J; Osnes T; Fosså SD; Bunne M
Laryngoscope; 2020 Sep; 130(9):E515-E521. PubMed ID: 32065408
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life.
Lubberts S; Groot HJ; de Wit R; Mulder S; Witjes JA; Kerst JM; Groenewegen G; Lefrandt JD; van Leeuwen FE; Nuver J; Schaapveld M; Gietema JA
J Clin Oncol; 2023 Jul; 41(19):3512-3522. PubMed ID: 37071834
[TBL] [Abstract][Full Text] [Related]
19. Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.
Feldman DR; Ardeshir-Rouhani-Fard S; Monahan P; Sesso HD; Fung C; Williams AM; Hamilton RJ; Vaughn DJ; Beard CJ; Cook R; Zaid MA; Lipshultz SE; Einhorn LH; Oeffinger KC; Travis LB; Fossa SD;
Clin Genitourin Cancer; 2018 Aug; 16(4):e761-e769. PubMed ID: 29534941
[TBL] [Abstract][Full Text] [Related]
20. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
